eubiologics

Products

Development and supply of safe and effective vaccine for global public health

Vaccine

Euvichol®

Euvichol® is an oral product developed to prevent cholera, which is prevalent in low-income countries, and has the advantage of not causing local adverse events such as pain, swelling, or rash at the injection site. In addition, with its simple administration method of shaking the vial and administering it immediately and its low price, it is being supplied to low-income countries suffering from cholera through the United Nations Children's Fund (UNICEF) and the Global Alliance for Vaccines and Immunization (GAVI). Euvichol® is the first product from a domestic bio venture company to receive WHO-PQ certification, and received WHO-PQ in December 2015 for its vial formulation.
Product Name Euvichol®(Inactivated oral cholera vaccine)
Product Purpose Prescription drugs (for export)
Dosage and Administration Administer orally twice at two-week intervals
Appearance A colorless, clear glass vial containing a yellow or slightly yellowish cloudy solution containing inactivated cholera bacteria.
Efficacy / Effectiveness Prevention of cholera caused by Vibrio cholerae serogroup O1 in children, adolescents, and adults over 1 year of age. (However, efficacy against Vibrio cholerae serogroup O139 has not been confirmed.)
Download manual
Euvichol-Plus

Product Components

Vaccine strain Quantity
V. cholerae O1 Inaba Cairo 48 (H) 300 L.E.U*
V. cholerae O1 Inaba Phil 6973 El Tor (F) 600 L.E.U
V. cholerae O1 Ogawa Cairo 50 (F) 300 L.E.U
V. cholerae O1 Ogawa Cairo 50(H) 300 L.E.U
V. cholerae O139 4260B (F) 600 L.E.U

H:Heat inactivated F:Formalin inactivated

* LEU : Lipopolysaccharide ELISA Units

Product Information

Usage/Capacity To save Validity
/Administer orally twice at two-week intervals Store at a temperature between 2℃ and 8℃ 24 months from manufacturing date